Camostat - an overview | ScienceDirect Topics Camostat is a protease inhibitor approved for the treatment of chronic pancreatitis Camostat appears to inhibit TMPRSS2 in proteomic and in vitro studies (7, 142)
Camostat: Uses, Dosage, Side Effects, Food Interaction FAQ Camostat is a serine protease indicated in Japan to treat chronic pancreatitis Camostat mesylate is indicated in Japan to treat chronic pancreatitis and drug induced lung injury It is also being investigated as a potential treatment for COVID-19
Camostat – Knowledge and References – Taylor Francis Camostat is an antiviral drug that inhibits serine protease enzymes such as TMPRSS2, reducing viral entry into host cells and preventing severe disease It is primarily used to treat postoperative reflux esophagitis and acute exacerbations of chronic pancreatitis